Terms: = Kidney tumors AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272
70 results:
1. Methylation of PCDH17 and NEFH as prognostic biomarker for nonmetastatic RCC: A cohort study.
Koudonas A; Papaioannou M; Kampantais S; Anastasiadis A; Hatzimouratidis K; Dimitriadis G
Medicine (Baltimore); 2022 Jul; 101(28):e29599. PubMed ID: 35838992
[TBL] [Abstract] [Full Text] [Related]
2. Genetic Analysis Reveals the Important Role of the
Lai YC; Wang WC
Anticancer Res; 2021 Sep; 41(9):4295-4304. PubMed ID: 34475049
[TBL] [Abstract] [Full Text] [Related]
3. Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis.
Diez-Calzadilla NA; Noguera Salvá R; Soriano Sarrió P; Martínez-Jabaloyas JM
Cancer Treat Res Commun; 2021; 27():100374. PubMed ID: 33932757
[TBL] [Abstract] [Full Text] [Related]
4. Characterization of renal cell carcinoma-associated constitutional chromosome abnormalities by genome sequencing.
Smith PS; Whitworth J; West H; Cook J; Gardiner C; Lim DHK; Morrison PJ; Hislop RG; Murray E; ; Tischkowitz M; Warren AY; Woodward ER; Maher ER
Genes Chromosomes Cancer; 2020 Jun; 59(6):333-347. PubMed ID: 31943436
[TBL] [Abstract] [Full Text] [Related]
5. Loss of heterozygosity of key tumor suppressor genes in advanced renal cancer patients treated with nivolumab.
Bersanelli M; Gnetti L; Azzoni C; Bottarelli L; Sverzellati N; Campanini N; Varotti E; Corrado M; Parziale R; Rapacchi E; Caruso G; Leonardi F; Silini EM; Buti S
Immunotherapy; 2018 Jul; 10(9):743-752. PubMed ID: 30008256
[TBL] [Abstract] [Full Text] [Related]
6. fhit and Wwox loss-associated genome instability: A genome caretaker one-two punch.
Schrock MS; Karras JR; Guggenbiller MJ; Druck T; Batar B; Huebner K
Adv Biol Regul; 2017 Jan; 63():167-176. PubMed ID: 27773744
[TBL] [Abstract] [Full Text] [Related]
7. Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer.
Skrypkina I; Tsyba L; Onyshchenko K; Morderer D; Kashparova O; Nikolaienko O; Panasenko G; Vozianov S; Romanenko A; Rynditch A
Dis Markers; 2016; 2016():3693096. PubMed ID: 27725787
[TBL] [Abstract] [Full Text] [Related]
8. Exome-wide single-base substitutions in tissues and derived cell lines of the constitutive fhit knockout mouse.
Paisie CA; Schrock MS; Karras JR; Zhang J; Miuma S; Ouda IM; Waters CE; Saldivar JC; Druck T; Huebner K
Cancer Sci; 2016 Apr; 107(4):528-35. PubMed ID: 26782170
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive exploration of novel chimeric transcripts in clear cell renal cell carcinomas using whole transcriptome analysis.
Gotoh M; Ichikawa H; Arai E; Chiku S; Sakamoto H; Fujimoto H; Hiramoto M; Nammo T; Yasuda K; Yoshida T; Kanai Y
Genes Chromosomes Cancer; 2014 Dec; 53(12):1018-32. PubMed ID: 25230976
[TBL] [Abstract] [Full Text] [Related]
10. Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma.
Williamson SR; Eble JN; Amin MB; Gupta NS; Smith SC; Sholl LM; Montironi R; Hirsch MS; Hornick JL
Mod Pathol; 2015 Jan; 28(1):80-94. PubMed ID: 25034258
[TBL] [Abstract] [Full Text] [Related]
11. Analysis of the t(3;8) of hereditary renal cell carcinoma: a palindrome-mediated translocation.
Kato T; Franconi CP; Sheridan MB; Hacker AM; Inagakai H; Glover TW; Arlt MF; Drabkin HA; Gemmill RM; Kurahashi H; Emanuel BS
Cancer Genet; 2014 Apr; 207(4):133-40. PubMed ID: 24813807
[TBL] [Abstract] [Full Text] [Related]
12. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract] [Full Text] [Related]
13. High-resolution genomic profiling of an adult Wilms' tumor: evidence for a pathogenesis distinct from corresponding pediatric tumors.
Karlsson J; Holmquist Mengelbier L; Elfving P; Gisselsson Nord D
Virchows Arch; 2011 Nov; 459(5):547-53. PubMed ID: 21947875
[TBL] [Abstract] [Full Text] [Related]
14. Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array.
Toma MI; Grosser M; Herr A; Aust DE; Meye A; Hoefling C; Fuessel S; Wuttig D; Wirth MP; Baretton GB
Neoplasia; 2008 Jul; 10(7):634-42. PubMed ID: 18592004
[TBL] [Abstract] [Full Text] [Related]
15. Cytogenetic studies of 24 renal epithelial tumors with von Hippel-Lindau and fragile histidine triad protein expression correlation.
Gayrard N; Cacheux V; Iborra F; Mourad G; Argilés A
Arch Pathol Lab Med; 2008 Jun; 132(6):965-73. PubMed ID: 18517280
[TBL] [Abstract] [Full Text] [Related]
16. Aberrant fhit transcripts in human colorectal cancers.
Lee SH; Lee SH
Res Commun Mol Pathol Pharmacol; 2005; 117-118():153-65. PubMed ID: 18426086
[TBL] [Abstract] [Full Text] [Related]
17. Hypermethylation of the 5'CpG island of the fhit gene in clear cell renal carcinomas.
Kvasha S; Gordiyuk V; Kondratov A; Ugryn D; Zgonnyk YM; Rynditch AV; Vozianov AF
Cancer Lett; 2008 Jul; 265(2):250-7. PubMed ID: 18378390
[TBL] [Abstract] [Full Text] [Related]
18. A constitutional balanced t(3;8)(p14;q24.1) translocation results in disruption of the TRC8 gene and predisposition to clear cell renal cell carcinoma.
Poland KS; Azim M; Folsom M; Goldfarb R; Naeem R; Korch C; Drabkin HA; Gemmill RM; Plon SE
Genes Chromosomes Cancer; 2007 Sep; 46(9):805-12. PubMed ID: 17539022
[TBL] [Abstract] [Full Text] [Related]
19. Biological functions of mammalian Nit1, the counterpart of the invertebrate Nitfhit Rosetta stone protein, a possible tumor suppressor.
Semba S; Han SY; Qin HR; McCorkell KA; Iliopoulos D; Pekarsky Y; Druck T; Trapasso F; Croce CM; Huebner K
J Biol Chem; 2006 Sep; 281(38):28244-53. PubMed ID: 16864578
[TBL] [Abstract] [Full Text] [Related]
20. Commutators of PAR-1 signaling in cancer cell invasion reveal an essential role of the Rho-Rho kinase axis and tumor microenvironment.
Nguyen QD; De Wever O; Bruyneel E; Hendrix A; Xie WZ; Lombet A; Leibl M; Mareel M; Gieseler F; Bracke M; Gespach C
Oncogene; 2005 Dec; 24(56):8240-51. PubMed ID: 16091733
[TBL] [Abstract] [Full Text] [Related]
[Next]
